Stay updated with breaking news from Trials Still. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Editor's Note: In a new report commissioned by the Leukemia & Lymphoma Society (LLS), Manatt Health examines the barriers that may prevent patients...
The 2-billion Vaccine Question: How realistic are estimates and what's the current status? SECTIONS Share Synopsis The Centre’s plan for 2 billion doses of Covid-19 vaccines by year-end depends on a massive ramp-up of production as well as flawless trials, approval and manufacturing of five new vaccines. How realistic are the estimates? In what stages are the new vaccines now? AP Amid a shortage of Covid-19 vaccines, which has seen many states suspend inoculation sessions, the Centre on May 13 announced that 2 billion doses would be available by the end of the year. This would be a signi...
Share this article Share this article ResearchAndMarkets.com's offering. Clinical Trials, the most crucial step in drug discovery has never been in the forefront in adopting new technologies and transforming from the conventional protocols. With the development of AI/ML in the last five years, it has opened up a new horizon for transforming clinical trials. It has been proven that use of AI/ML tools can scan through large volumes of data and provide accurate results within minutes which takes enormous time when performed by humans. Application of analytical tools help identify trends and pa...